| Literature DB >> 7431555 |
E A Friedman, M M Beyer, S R Hirsch, G Schiffman.
Abstract
To test their immune responsiveness to pneumococcal polysaccharide antigens, eight azotemic patients, ten dialysis patients, and five insulin-dependent diabetics were vaccinated with a 14-valent vaccine. When compared with nonazotemic, nondiabetic control subjects, both diabetics and uremic patients responded with normal antibody titers to each antigen type. Therefore, we are advising immunization with commercially available vaccine in our patients with diabetes, renal failure, or both, although long-term efficacy has yet to be proved.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7431555
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272